Form 4 for DMAC DiaMedica Therapeutics Inc.
Accepted 2023-06-27 00:00:00 ET · period of report 2023-06-23 · accession 0001104659-23-075250 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-06-27 | 2023-06-23 | DMAC | TomEqt Private AB | 10% | P - Purchase | $3.40 | +1.47M | 4.33M | +51% | +$5.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-06-23 | P | A | 1,470,588 | $3.40 | 4,326,435 | I See Footnote 1 | — | — | (F1) These shares are owned directly by TomEqt Private AB and indirectly by Thomas Von Koch in his capacity as the board member of TomEnterprise AB. Thomas Von Koch had the sole power to vote and dispose of these shares. |